| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Warren Eric is a Chief Commercial Officer at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 107 | $7.69 | $822.83 | -0.2% | -12.2% | -88.8% | |
| Sep 19, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 255 | $6.92 | $1,764.86 | -0.5% | -20.8% | -83.4% | |
| Aug 31, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Buy | 1,000 | $7.46 | $7,460.00 | +1.9% | -12.3% | -78.6% | |
| Aug 17, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 199 | $6.82 | $1,356.19 | -0.4% | +4.3% | -79.4% | |
| Jul 19, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 431 | $6.58 | $2,836.84 | -0.8% | +16.8% | -76.5% | |
| Jun 17, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 256 | $4.90 | $1,254.40 | -0.5% | +34.3% | -74.6% | |
| May 17, 2022 | ESPR Esperion Therapeutics, Inc. | Chief Commercial Officer | Sell | 196 | $5.98 | $1,172.28 | -0.4% | +2.3% | -73.0% |